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Abstract: The aim of the present study was to examine the potential role and applicability of dietary 
supplements in reducing the risk of development of amyloid diseases associated with the gastrointes-
tinal tract, such as type II diabetes. Trypsin, a well-known serine protease was used as a model pro-
tein in our experiments.  The effect of various red wines on the formation of amyloid-like fibrils of 
trypsin was studied in vitro, in aqueous ethanol, at pH 7.0. Turbidity measurements, aggregation 
kinetics experiments, Congo red binding assays and electronic circular dichroism spectroscopic 
measurements were used to follow the aggregation process in the presence or absence of various red 
wines. The results suggest that red wines effectively inhibit the formation of amyloid-like fibrils of 
trypsin and the inhibitory effect is dose-dependent. The extent of inhibition was found to be propor-
tional to the total concentration of phenolic compounds.  
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1. INTRODUCTION 
 Amyloid formation might be a general property of the 
polypeptide backbone as all proteins can form long-
unbranched, β-sheet rich amyloid fibrils in vitro under ap-
propriate conditions [1–2]. There are striking similarities in 
the aggregation behavior of different peptides and proteins. 
Unfolded or partially unfolded proteins associate with each 
other to form small, soluble aggregates that undergo further 
assembly into protofibrils or protofilaments. These structures 
are commonly short, thin, sometimes curved, fibrillar species 
that are presumed to assemble into mature fibrils. Experi-
ments in vitro indicate that the formation of such species is 
generally characterized by a lag phase, followed by a period 
of rapid growth. This phenomenon is associated with com-
mon and highly debilitating diseases. An increasing number 
of disorders, including Alzheimer's and Parkinson's diseases, 
spongiform encephalopathy and type II diabetes, are directly 
associated with the deposition of such aggregates in brain, 
heart and spleen tissue. Amyloid diseases predominantly 
involve the aggregation of specific proteins, such as the 
prion protein or the amyloid β-peptide, but fibrils can be 
formed by many other peptides and proteins [3]. Natural 
phenolic compounds, a long family of plant substances, are 
one of the most actively investigated categories of potential 
amyloid inhibitors [4–6]. More than 8,000 plant polyphenols 
are currently known and more than 4,000 flavonoids have 
been identified among them [7]. Red wine represents a rich 
source of polyphenols such as flavonoids (flavanol  
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monomers, condensed tannins, flavonols, anthocyanins) as 
well as non-flavonoids (hydroxycinnamates, benzoic acids, 
hydrolyzable tannins and stilbenes (resveratrol)) [8]. Res-
veratrol, a polyphenolic red wine constituent, inhibits Aβ42 
fibril formation and islet amyloid polypeptide aggregation in 
a dose-dependent manner [9-10]. The inhibitory effect of 
flavone derivatives is dependent on the number and position 
of hydroxyl groups around the flavone backbone [11]. The 
position of phenolic hydroxyl moieties on the aromatic rings 
is a major determinant of the potent anti-aggregation effect, 
while the number of hydroxyl groups is less important [12]. 
Natural phenolic and polyphenolic substances stabilize na-
tive states, or remodel and inactivate toxic amyloid oli-
gomers [4]. Several observations suggest that polyphenols 
inhibit amyloid fibril formation through specific aromatic 
interactions with the amyloidogenic core [13]. Aromatic 
rings of polyphenolic compounds and the aromatic residues 
present in proteins may associate via π-π stacking interac-
tions [14]. The hydrophobic and/or aromatic character of 
these compounds contributes significantly to the anti-
amyloidogenic effect, whereas the antioxidative potency 
relates mostly to the destabilization of fibrils [15]. Studies 
have shown that the presence of vicinal dihydroxyphenyl 
moieties, irrespective of their position in the aromatic rings, 
play a key role in the inhibitory property of polyphenols [16–
17]. Non-flavonoids showed higher anti-aggregation activity 
than flavonoids. Polyphenols containing a higher number of 
aromatic rings, hydroxyl and keto groups and possess a high 
degree of planarity, have the largest inhibititory activity [18]. 
A structure–function relationship study suggested that the 
presence of at least two phenolic rings with two to six atom-
long linkers, along with a minimum number of three hy-
droxyl groups on the aromatic rings, are essential for effi-
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cient inhibition exerted by polyphenols [5]. The mechanism 
of inhibition of amyloid formation is not identical for all 
natural polyphenols. Some inhibit the formation of oli-
gomers, but promote fibril formation, others inhibit the for-
mation of fibrils, but not oligomers, and there are others, 
which inhibit both. Other polyphenols redirect amyloid fi-
brils from fibrillogenic forms to nonfibrillogenic oligomers 
[19]. Polyphenols induce conformational changes in the oli-
gomer aggregate. These changes disrupt H-bonds and per-
turb the amyloid aggregate. Polyphenol molecules separate 
the β-sheets, which leads to a loosely packed structure. H-
bonding capacity of polyphenols is responsible for this be-
havior [20]. Flavonoids, phenols in particular, represent an 
important component of a normal human diet. Elevated in-
take of dietary polyphenols might be relevant to the preven-
tion of amyloidosis. Nutraceutical strategies might become a 
way to reduce the risk of certain amyloid diseases [19, 21]. 
Many drugs used today are natural products or derivatives of 
natural products [22–23]. 
  Earlier we have demonstrated that phenylmethylsul-
fonyl-trypsin (PMS-trypsin) forms amyloid-like fibrils in 
60% (v/v) ethanol/10 mM phosphate buffer (PBS) at pH = 
7.0 [24]. Here, we report that various red wines inhibit the 
formation of amyloid-like fibrils of PMS-trypsin dose-
dependently.  
2. MATERIALS AND METHODS  
2.1. Materials 
 Bovine pancreas trypsin (EC 3.4.21.4), gallic acid and N-
benzoyl-L-arginine ethyl ester (BAEE) were purchased from 
Sigma-Aldrich Company (Budapest, Hungary). Folin–
Ciocalteu’s phenol reagent was the product of Merck (Darm-
stadt, Germany). Red wines were purchased from commer-
cially sources:  La Bonita Cabernet Franc semi-sweet and 
Pincegyöngye Édes Vörös sweet red wines bottled by Heli-
bor Ltd., H-6070 Izsák; Transdanubian Merlot sweet red 
wine, bottled by Szent Imre Wine-cellar Ltd., H-6223 
Soltszentimre; La Fiesta Kékfrankos semi-sweet red wine, 
bottled by Grape-Vine Ltd., H-6120 Kiskunmajsa; Egri bi-
kavér 2012 dry red wine, bottled by Ostoros-Novaj Bor Co., 
H-3327 Novaj; Portugieser 2014 dry red wine, bottled by 
Dolium Wine-cellar Ltd., H-7773 Villány. 
2.2. General Methods 
 Trypsin concentration was determined based on the UV 
absorbance of the constituent aromatic and cystine residues 
at 280 nm, using a calibration curve measured for trypsin in 
the 0-1 mg/mL concentration range. Spectroscopic samples 
have been corrected for respective solvent backgrounds in all 
experiments where applicable. 
2.3. Assay of Enzyme Activity 
 Trypsin activity, with BAEE as a substrate, was deter-
mined using the method of Schwert and Takenaka [25]. The 
absorption increase at 253 nm was measured in a 3 mL reac-
tion mixture, containing 46.7 mM Tris/HCl (pH 8.0) and 0.9 
mM BAEE. The reaction was started by the addition of 20 
µL enzyme sample (0.15 mg/mL).  
2.4. Trypsin Modification with Phenylmethylsulfonyl 
Fluoride (PMSF) 
 Chemical modification with PMSF inactivates trypsin 
irreversibly. Thus the autolysis of enzyme at pH = 7.0 does 
not affect the experiments. Solutions of 8.4 µL PMSF (100 
mM) in 2-propanol and 20 µL trypsin (50 mg/mL) in 0.001 
M HCl were added to 2 mL 0.05 M PBS (pH = 7.0) at 24 oC 
while the solution was stirred. During the procedure identical 
amounts of reactants were added four times, repeatedly to 
the solution. The enzyme sample was incubated for 30 min. 
The reaction mixture was then filtered on a Sephadex G-25 
column in 0.05 M PBS (pH = 7.0), to remove the unreacted 
inhibitor molecules. The degree of conversion was deter-
mined by enzymatic activity assays, of which results indi-
cated that 95% of the trypsin had been modified. 
2.5. Turbidity Measurements 
 In order to estimate the amount of fibrillar material, tur-
bidity of PMS-trypsin solutions was monitored by UV-vis 
spectrophotometry at 350 nm and 24 oC, using a quartz cu-
vette of 10 mm path length. Turbidity experiments were per-
formed in 0.13 mg/mL solutions of PMS-trypsin in 60% 
(v/v) ethanol/10 mM PBS (pH = 7.0) after 24 h incubation in 
the presence or absence of red wines at a 50-fold final dilu-
tion.  
2.6. Determination of Total Phenolic Content 
 The total phenolic content of red wine samples was de-
termined utilizing the Folin-Ciocalteu reagent and the spec-
trophotometric method of Waterhouse [26]. For calibration, 
gallic acid solutions of different concentrations (0–50 mg/L) 
were used. The total phenolic content was expressed as mg 
gallic acid equivalents (GAE) per liter of red wine. The data 
presented are the average of three measurements. 
2.7. Aggregation Kinetics 
 Aggregation experiments were performed in 60% (v/v) 
ethanol/10 mM PBS (pH = 7.0) at 0.13 mg/mL PMS-trypsin 
concentration and various concentrations of red wine. The 
increase of UV absorption at 350 nm, indicative of the pres-
ence of large aggregated particles, was followed for 30 min 
at 24 oC and pH 7.0.  
2.8. CR Binding 
 Absorption spectra of Congo red (CR) were recorded in 
the range of 400–600 nm using a 10 mm path length quartz 
cuvette. Samples were prepared at a protein concentration of 
0.285 mg/mL. Two hundred µL 1-day-aged PMS-trypsin 
samples in 60% (v/v) ethanol, in the absence or presence of 
Egri bikavér, were vortexed with 800 µL of a solution con-
taining 4.9 µM CR, 5 mM PBS and 150 mM NaCl (pH 7.0) 
and was incubated at room temperature for 15 min before the 
measurements. Difference spectra were obtained by subtract-
ing the spectra of CR alone and PMS-trypsin alone from 
spectra of solutions containing both PMS-trypsin and CR. 
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2.9. ECD Measurements 
 Electronic circular dichroism (ECD) measurements were 
carried out using a Jasco J-815 spectropolarimeter. Spectra 
were recorded in the range of 185–260 nm in a 1 mm path 
length cell at 24 oC.  PMS-trypsin was dissolved in 60% 
(v/v) ethanol/10 mM PBS (pH 7.0) at a concentration of 0.15 
mg/mL. Red wine was contained in the samples at a 50-fold 
dilution.  
3. RESULTS AND DISCUSSION 
 PMS-trypsin amyloid-like fibrils were prepared in aque-
ous ethanol according to our previous report [24]. To deter-
mine whether red wines affect fibril formation of PMS-
trypsin, samples were incubated in aqueous ethanol at pH 
7.0, in the presence and absence of different red wines. Ag-
gregation of PMS-trypsin can be monitored by turbidity 
measurements. An increase in the UV absorbance at 350 nm 
indicates a greater degree of aggregation due to an increase 
in the scattering of light by aggregated particles [16]. In the 
absence of red wines, higher absorbance values were ob-
served indicating higher degree of  turbidity and that red 
wines have the ability to effectively inhibit PMS-trypsin fi-
bril formation in vitro (Figure 1). These experiments re-
vealed that the greatest effect was exerted by the red wine 
Egri bikavér in 60% (v/v) ethanol/10 mM PBS (pH = 7.0). 
The absorption at 350 nm decreased to 51.9% relative to the 
reference sample after incubation for 24 h in the presence of 









Figure 1. Turbidity changes of PMS-trypsin at 24 oC in 60% (v/v) 
ethanol/10 mM PBS (pH = 7.0), monitored via the absorption at 
350 nm after incubation for 24 h in the presence of various red 
wines at 50-fold dilution. The protein concentration was 0.13 
mg/mL. 
 
 The total concentration of phenolic compounds of vari-
ous red wines varied from 1,053 to 2,354 mg GAE/L (Figure 
2). The degree of inhibition was found to be proportional to 
the total phenolic content. Figure 3 illustrates that red wine 
led to a dose-dependent decrease in the absorption. 
 CR is a planar, hydrophobic, diazo dye, which binds to 
the β-sheet of amyloid and amyloid-like fibrils selectively, 
therefore it is a commonly used agent to detect amyloid fi-
brils. Binding of CR to amyloid generally results in an in-
crease and a characteristic red shift (from 490 nm to 540 nm) 
of light absorption [27–28]. A moderate red shift of the ab-













Figure 2. Inhibition of amyloid-like fibril formation as a function 
of total phenolic content. Percentage of inhibition in 60% (v/v) 
ethanol (●), total phenolic content (○). Red wines were diluted 50-
fold in 60% (v/v) ethanol/10 mM PBS (pH = 7.0). The protein con-
centration was 0.13 mg/mL.  
 
in the visible spectra of CR in the presence of PMS-trypsin 
in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) (Figure 4).  
Difference spectra indicate spectral changes of CR upon 
binding to PMS-trypsin amyloid fibrils in the absence or 
presence of 25 to 250-fold diluted red wine, Egri bikavér. 
This suggests that the aggregates have amyloid-like proper-
ties in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) and the 
active components of Egri bikavér inhibit the formation of 












Figure 3. Kinetics of aggregation of PMS-trypsin without red wine 
(•) in 60% (v/v) ethanol/10 mM PBS (pH = 7.0), or in the presence 
of Merlot wine diluted 50- (∆), 1000- (○), or 4000-fold (x), moni-
tored via the time-dependent increase of UV absorption at 350 nm, 
at 0.13 mg/mL protein concentration. 
 
Changes in the secondary structure of PMS-trypsin were 
followed by ECD measurements. ECD spectra of PMS-
trypsin in 60% (v/v) ethanol/10 mM PBS (pH = 7.0), meas-
ured in the presence or in the absence of 50-fold diluted Egri 
bikavér are shown in Figure 5. Measurements were carried  
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out by placing the cuvette either in the middle of the sample 
compartment or next to the detector. For clear, homogenous 
samples the two measurements shall provide identical re-
sults. Remarkable change in the intensity and a blue shift of 
the 217 nm minimum was observed in the absence of red 
wine, upon moving the cuvette from the middle of the sam-
ple compartment towards the detector, indicating aggregated 
particles in the sample. Light dispersion of the sample was 
significantly decreased by the addition of 50-fold diluted 
Egri bikavér wine, suggesting that a lower amount of aggre-
gates is present compared to the sample not containing the 
additive. It was shown previously, that high concentrations 
of ethanol promote structural transitions of PMS-trypsin, 
resulting in an increase of β-sheet structure of the protein 













Figure 5. ECD spectra of PMS-trypsin in 60% (v/v) ethanol/10 mM 
PBS (pH = 7.0) in the absence (solid line, dashed line) and in the 
presence of 50-fold diluted Egri bikavér (dotted-dashed line, dotted 
line). The sample was set either in the middle of the sample com-
partment (solid line, dashed-dotted line), or next to the detector 
(dashed line, dotted line). PMS-trypsin concentration was 0.15 
mg/mL. 
by the addition of diluted red wine. Conversely, ECD spectra 
recorded in different cuvette positions suggest, that addition 
of red wine do not arrest transition from native to β-sheet 
structure, but it may inhibit intermolecular associations and 
the formation of large aggregates. 
CONCLUSIONS 
 Results of the present in vitro study demonstrated that red 
wines inhibit the aggregation of PMS-trypsin in 60% (v/v) 
ethanol/10 mM PBS (pH = 7.0) in a dose-dependent manner. 
The inhibitory effect was found to correlate with the amount 
of natural phenolic and polyphenolic substances contained in 
red wines. Although further studies are needed to verify di-
rect applicability of red wine or its active components, our 
results suggest that moderate red wine consumption may 
constitute a part of a preventive dietary strategy against amy-
loidogenic diseases of the gastrointestinal tract. Among the 
examined red wines Egri bikavér demonstrated the strongest 
inhibitory effect on trypsin fibril formation. 
LIST OF ABBREVIATIONS 
BAEE = N-benzoyl-L-arginine ethyl ester  
ECD = electronic circular dichroism  
CR = Congo red  
GAE = gallic acid equivalent  
PBS = phosphate buffered saline  
PMSF = phenylmethylsulfonyl fluoride 
CONFLICT OF INTEREST 
 The authors confirm that this article content has no con-
flicts of interest. 
ACKNOWLEDGMENTS 
 Ph. D. scholarship was provided for P. B. K. by the Tem-








             A                                                                                                                 B 
Figure 4. Visible absorption spectra of PMS-trypsin stained with CR in 60% (v/v) ethanol/10 mM PBS (pH = 7.0): PMS-trypsin + CR (A, 
solid line), CR alone (A, dashed line), PMS-trypsin alone (A, dotted line) and difference spectra in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) 
without red wine (B, solid line) or in the presence of Egri bikavér wine in 25- (B, dashed line) and 250-fold (B, dotted line) final dilution. 
Spectra were recorded at 3.9 µM and 57 µg/mL dye and protein concentrations, respectively. 
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